Literature DB >> 18753747

Sudden deafness and right-to-left shunts.

Yasuyuki Iguchi1, Kazumi Kimura, Kazuto Kobayashi, Toshihiro Tachi, Teruhito Aihara, Tamotsu Harada.   

Abstract

PURPOSE: One of the etiologies for idiopathic sudden deafness is considered to be ischemia of the inner ear. Cryptogenic stroke is caused by a right-to-left shunt (RLS). The present study investigated whether RLS is associated with the occurrence of sudden deafness.
METHODS: Contrast saline transcranial Doppler ultrasonography was performed to detect RLS. Subjects comprised 23 consecutive sudden deafness patients and 46 age- and gender-matched controls. Clinical characteristics, including vascular risk factors, were compared between sudden deafness and control groups.
RESULTS: RLS was more frequent in the sudden deafness group than in controls (48 vs. 17%, p = 0.011). No significant differences in other clinical characteristics were seen between groups.
CONCLUSION: RLS may be a potential cause of sudden deafness. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18753747     DOI: 10.1159/000151682

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  3 in total

1.  Response to the letter to the editor: "Score risk scale as a prognostic factor after sudden sensorineural hearing loss".

Authors:  Ana Sousa Menezes; Daniela Ribeiro; António Lima; Daniel Miranda; Joana Guimarães; Luís Dias
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-02       Impact factor: 2.503

2.  Patent Foramen Ovale as Possible Cause of Sudden Sensorineural Hearing Loss: A Case Report.

Authors:  Andrea Ciorba; Virginia Corazzi; Luca Cerritelli; Chiara Bianchini; Giovanni Scanelli; Claudia Aimoni
Journal:  Med Princ Pract       Date:  2017-10-16       Impact factor: 1.927

3.  Foramen ovale closure is a process of endothelial-to-mesenchymal transition leading to fibrosis.

Authors:  Graeme C Elliott; Rockesh Gurtu; Charles McCollum; William G Newman; Tao Wang
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.